Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Atorvastatin improves eGFR regardless of metabolic syndrome state in CHD patients

Nov. 23, 2009

ATI-2042 effective at reducing atrial fibrillation burden in phase II trial

Nov. 23, 2009

AdCD40L immunotherapy for bladder cancer deemed safe in phase I/IIa trials

Nov. 23, 2009

AT-13387 shows promising antitumor activity in mouse xenograft models

Nov. 23, 2009

Preliminary results reported from first-in-human study of FP-1039

Nov. 23, 2009

Phase II data support antitumor activity of tasisulam in platinum-resistant ovarian cancer

Nov. 23, 2009

Insight into the mechanism of action of ATI-5261, a novel synthetic peptide

Nov. 20, 2009

Chymase inhibitor improves left ventricular function after mitral regurgitation

Nov. 20, 2009

VALIANT study results suggest increased HR is predictive of worse outcome in post-MI

Nov. 20, 2009

TB-403 shown to be safe in healthy males and cancer patients in phase I trials

Nov. 20, 2009

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...